We're three years out after our initial discoveries of nitrosamine impurities in major medications, and the industry is continuing to see the ripple effects. On March 23, 2022, The New York Times released an article titled, “Pfizer Recalls Some Blood Pressure Drugs, Citing Cancer Risk,”  where FDA Reporter, Christina Jewett, covers recalls due to this contamination and how Valisure's past findings have ensued the wave of recalls.

Via the full article via The New York Times here.

‍

We're three years out after our initial discoveries of nitrosamine impurities in major medications, and the industry is continuing to see the ripple effects. On March 23, 2022, The New York Times released an article titled, “Pfizer Recalls Some Blood Pressure Drugs, Citing Cancer Risk,”  where FDA Reporter, Christina Jewett, covers recalls due to this contamination and how Valisure's past findings have ensued the wave of recalls.

Via the full article via The New York Times here.

‍